Article: The RANK ligand inhibitor denosumab as novel therapeutic agent in the spectrum of cancer bone disease

€2.42

SKU: product-article-11135 Category: General

Description

Description

The RANK ligand inhibitor denosumab as novel therapeutic agent in the spectrum of cancer bone disease

Top

Article: The RANK ligand inhibitor denosumab as novel therapeutic agent in the spectrum of cancer bone disease

Description

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in breast cancer

Article: Highlights in respiratory oncology